Literature DB >> 17826472

Compensatory strategies used by older adults facing mobility disability.

Carlos O Weiss1, Helen M Hoenig, Linda P Fried.   

Abstract

Preclinical disability in mobility tasks can be recognized by asking people without overt mobility disability whether they have changed the way, either the manner or the frequency, of doing a mobility task because of a health or physical condition. Like other compensatory strategies, preclinical mobility disability has a dual nature as both a risk marker associated with impairment or limitation and a mediating factor affecting the natural history of disability. The method of ascertaining preclinical disability through self-report has been shown to have construct validity, to be reliable, and to identify people at an elevated risk of developing overt mobility disability over 1 to 2 years. Many worthy research questions in this field remain to be addressed, especially regarding qualitative heterogeneity (doing more vs doing less) and interactions among compensatory strategies. Nonetheless, there is sufficient evidence to apply what is known about preclinical disability to screening in clinical settings. This area of research and practice constitutes an opportunity for physical medicine and rehabilitation and geriatric medicine to jointly make a large beneficial impact on population health through strategies to prevent disability because rapidly growing numbers of older adults will experience this early and potentially malleable stage.

Entities:  

Mesh:

Year:  2007        PMID: 17826472     DOI: 10.1016/j.apmr.2007.07.007

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  16 in total

1.  Pro-dromal sarcopenia.

Authors:  D L Waters
Journal:  J Nutr Health Aging       Date:  2011-12       Impact factor: 4.075

2.  Performance-based versus patient-reported physical function: what are the underlying predictors?

Authors:  Jonathan F Bean; Daniele D Olveczky; Dan K Kiely; Sharon I LaRose; Alan M Jette
Journal:  Phys Ther       Date:  2011-10-14

3.  Coping with preclinical disability: older women's experiences of everyday activities.

Authors:  Rebecca Ann Lorenz
Journal:  J Nurs Scholarsh       Date:  2010-12       Impact factor: 3.176

Review 4.  Assessment of physical functioning: a conceptual model encompassing environmental factors and individual compensation strategies.

Authors:  Kristin M Tomey; Maryfran R Sowers
Journal:  Phys Ther       Date:  2009-05-14

5.  Transitions among disability levels or death in African American and white older women.

Authors:  Roland J Thorpe; Carlos Weiss; Qian-Li Xue; Linda Fried
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-19       Impact factor: 6.053

6.  Exploring older adults' patterns and perceptions of exercise after hip fracture.

Authors:  Erin Gorman; Anna M Chudyk; Christiane A Hoppmann; Heather M Hanson; Pierre Guy; Joanie Sims-Gould; Maureen C Ashe
Journal:  Physiother Can       Date:  2013       Impact factor: 1.037

7.  Adopting the ICF language for studying late-life disability: a field of dreams?

Authors:  Vicki A Freedman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-07-17       Impact factor: 6.053

8.  Assistive devices in context: cross-sectional association between challenges in the home environment and use of assistive devices for mobility.

Authors:  Christopher L Seplaki; Emily M Agree; Carlos O Weiss; Sarah L Szanton; Karen Bandeen-Roche; Linda P Fried
Journal:  Gerontologist       Date:  2013-04-24

9.  Subclinical disability in valued life activities among individuals with rheumatoid arthritis.

Authors:  Patricia Katz; Anne Morris; Edward Yelin
Journal:  Arthritis Rheum       Date:  2008-10-15

10.  Physical and mental health-related correlates of physical function in community dwelling older adults: a cross sectional study.

Authors:  Carol Ewing Garber; Mary L Greaney; Deborah Riebe; Claudio R Nigg; Patricia A Burbank; Phillip G Clark
Journal:  BMC Geriatr       Date:  2010-02-03       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.